These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
502 related articles for article (PubMed ID: 17381073)
21. [Structure-activity relationship in the enzymatic hydrolysis of dipeptide aryl amides by dipeptidyl peptidase IV]. Barth A; Mager H; Fischer G; Neubert K; Schwarz G Acta Biol Med Ger; 1980; 39(11-12):1129-42. PubMed ID: 7018141 [TBL] [Abstract][Full Text] [Related]
22. Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas. Stremenová J; Mares V; Lisá V; Hilser M; Krepela E; Vanicková Z; Syrucek M; Soula O; Sedo A Int J Oncol; 2010 Feb; 36(2):351-8. PubMed ID: 20043068 [TBL] [Abstract][Full Text] [Related]
23. Substituted 4-carboxymethylpyroglutamic acid diamides as potent and selective inhibitors of fibroblast activation protein. Tsai TY; Yeh TK; Chen X; Hsu T; Jao YC; Huang CH; Song JS; Huang YC; Chien CH; Chiu JH; Yen SC; Tang HK; Chao YS; Jiaang WT J Med Chem; 2010 Sep; 53(18):6572-83. PubMed ID: 20718420 [TBL] [Abstract][Full Text] [Related]
24. Clinical implications of fibroblast activation protein in patients with colon cancer. Henry LR; Lee HO; Lee JS; Klein-Szanto A; Watts P; Ross EA; Chen WT; Cheng JD Clin Cancer Res; 2007 Mar; 13(6):1736-41. PubMed ID: 17363526 [TBL] [Abstract][Full Text] [Related]
25. Neuropeptide Y, B-type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein-α. Keane FM; Nadvi NA; Yao TW; Gorrell MD FEBS J; 2011 Apr; 278(8):1316-32. PubMed ID: 21314817 [TBL] [Abstract][Full Text] [Related]
26. Characterization of the endopeptidase activity of tripeptidyl-peptidase II. Eklund S; Dogan J; Jemth P; Kalbacher H; Tomkinson B Biochem Biophys Res Commun; 2012 Aug; 424(3):503-7. PubMed ID: 22771804 [TBL] [Abstract][Full Text] [Related]
27. Human dipeptidyl peptidase III: insights into ligand binding from a combined experimental and computational approach. Tomić A; Abramić M; Spoljarić J; Agić D; Smith DM; Tomić S J Mol Recognit; 2011; 24(5):804-14. PubMed ID: 21812054 [TBL] [Abstract][Full Text] [Related]
28. Structure and function in dipeptidyl peptidase IV and related proteins. Gorrell MD; Wang XM; Park J; Ajami K; Yu DM; Knott H; Seth D; McCaughan GW Adv Exp Med Biol; 2006; 575():45-54. PubMed ID: 16700507 [No Abstract] [Full Text] [Related]
29. The metal-binding motif of dipeptidyl peptidase III directly influences the enzyme activity in the copper derivative of dipeptidyl peptidase III. Hirose J; Kamigakiuchi H; Iwamoto H; Fujii H; Nakai M; Takenaka M; Kataoka R; Sugahara M; Yamamoto S; Fukasawa KM Arch Biochem Biophys; 2004 Nov; 431(1):1-8. PubMed ID: 15464720 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and structure-activity relationship of N-acyl-Gly-, N-acyl-Sar- and N-blocked-boroPro inhibitors of FAP, DPP4, and POP. Tran T; Quan C; Edosada CY; Mayeda M; Wiesmann C; Sutherlin D; Wolf BB Bioorg Med Chem Lett; 2007 Mar; 17(5):1438-42. PubMed ID: 17174090 [TBL] [Abstract][Full Text] [Related]
31. A Single Second Shell Amino Acid Determines Affinity and Kinetics of Linagliptin Binding to Type 4 Dipeptidyl Peptidase and Fibroblast Activation Protein. Schnapp G; Hoevels Y; Bakker RA; Schreiner P; Klein T; Nar H ChemMedChem; 2021 Feb; 16(4):630-639. PubMed ID: 33030297 [TBL] [Abstract][Full Text] [Related]
32. Absolutely conserved tryptophan in M49 family of peptidases contributes to catalysis and binding of competitive inhibitors. Spoljarić J; Salopek-Sondi B; Makarević J; Vukelić B; Agić D; Simaga S; Jajcanin-Jozić N; Abramić M Bioorg Chem; 2009 Jun; 37(3):70-6. PubMed ID: 19375145 [TBL] [Abstract][Full Text] [Related]
33. Tripeptidyl-peptidase II: a multi-purpose peptidase. Tomkinson B; Lindås AC Int J Biochem Cell Biol; 2005 Oct; 37(10):1933-7. PubMed ID: 16125107 [TBL] [Abstract][Full Text] [Related]
34. Fibroblast activation protein-alpha and dipeptidyl peptidase IV (CD26): cell-surface proteases that activate cell signaling and are potential targets for cancer therapy. Kelly T Drug Resist Updat; 2005; 8(1-2):51-8. PubMed ID: 15939342 [TBL] [Abstract][Full Text] [Related]
35. Expression profiling of dipeptidyl peptidase 8 and 9 in breast and ovarian carcinoma cell lines. Wilson CH; Abbott CA Int J Oncol; 2012 Sep; 41(3):919-32. PubMed ID: 22736146 [TBL] [Abstract][Full Text] [Related]
36. Fibroblast activation protein (FAP) is upregulated in myelomatous bone and supports myeloma cell survival. Ge Y; Zhan F; Barlogie B; Epstein J; Shaughnessy J; Yaccoby S Br J Haematol; 2006 Apr; 133(1):83-92. PubMed ID: 16512833 [TBL] [Abstract][Full Text] [Related]
37. Association and dissociation of the tripeptidyl-peptidase II complex as a way of regulating the enzyme activity. Tomkinson B Arch Biochem Biophys; 2000 Apr; 376(2):275-80. PubMed ID: 10775413 [TBL] [Abstract][Full Text] [Related]
38. Rapid parallel synthesis of dipeptide diphenyl phosphonate esters as inhibitors of dipeptidyl peptidases. Senten K; Daniëls L; Van der Veken P; De Meester I; Lambeir AM; Scharpé S; Haemers A; Augustyns K J Comb Chem; 2003; 5(3):336-44. PubMed ID: 12739951 [TBL] [Abstract][Full Text] [Related]
39. Selectivity among dipeptidyl peptidases of the S9b family. Bjelke JR; Kanstrup AB; Rasmussen HB Cell Mol Biol (Noisy-le-grand); 2006 Dec; 52(4):3-7. PubMed ID: 17543192 [TBL] [Abstract][Full Text] [Related]
40. Dipeptidyl peptidase IV: development, design, synthesis and biological evaluation of inhibitors. Borloo M; De Meester I Verh K Acad Geneeskd Belg; 1994; 56(1):57-88. PubMed ID: 7911611 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]